Magnetic Resonance - Technology Information Portal Welcome to MRI Technology••


The impact of TTIP/TPP on the MRI scanner market will bring :
more variety 
better scanners 
more risk 
less regulation 
cheaper scanners 
Lost in Translation 
no change at all 

MRI News Service:
'Motexafin Gadolinium'
Result: Searchterm 'Motexafin Gadolinium' found in 2 news
Result Pages
More Results: Database  (2)  Resources  (1)  
News Refinements:  Contrast Agents  Devices  Financial  
Pharmacyclics Announces Positive Final Results of Phase 2 Trial of Xcytrin(R) Plus Radiosurgery for Brain Metastases With Occult Tumors Detected in 24% of Patients
'''CHICAGO and SUNNYVALE, Calif., June 3 /PRNewswire-FirstCall/ -- Pharmacyclics, Inc. (Nasdaq: PCYC) today announced final results from an open-label multi-center Phase 2 clinical trial, which indicated that Xcytrin(R) (motexafin gadolinium) ...'
Sunday, 3 June 2007   by
Pharmacyclics Announces Results from Phase 3 Smart Trial of Xcytrin(R) for Lung Cancer Brain Metastases
'''SUNNYVALE, Calif., Dec 19, 2005 /PRNewswire-FirstCall via COMTEX News Network/ -- Pharmacyclics, Inc. (Nasdaq: PCYC) today announced top-line results from its pivotal Phase 3 clinical study of Xcytrin(R) (motexafin gadolinium) Injection, for the ...'
Monday, 19 December 2005   by
News Refinements:  Contrast Agents  Devices  Financial  
Radiology News Open this link in a new window Ultrasound Imaging News Open this link in a new window
Result Pages
Age is not a particularly interesting subject. Anyone can get old. All you have to do is live long enough.
- Groucho Marx
Share This Page

Forgot your UserID/Password ?  

      Ups uses cookies! By browsing, you agree to our use of cookies.

Magnetic Resonance - Technology Information Portal
Member of SoftWays' Medical Imaging Group - MR-TIP • Radiology-TIP • US-TIP • 
Copyright © 2003 - 2018 SoftWays. All rights reserved. [ 22 January 2019]
Terms of Use | Privacy Policy | Advertising
 [last update: 2018-03-08 05:11:00]